HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers.
暂无分享,去创建一个
M. Lazdunski | J. Barhanin | C. Chouabe | G. Romey | M. Drici | M Lazdunski | G Romey | C Chouabe | J Barhanin | M D Drici | Jacques Barhanin | Christophe Chouabe | M.-D. Drici | Michel Lazdunski
[1] A. Brown,et al. Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart. , 1993, Molecular pharmacology.
[2] S. Grissmer,et al. Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3. , 1996, Molecular pharmacology.
[3] B. Massie. Mibefradil: a selective T-type calcium antagonist. , 1997, The American journal of cardiology.
[4] Lack of Triggered Automaticity Despite Repolarization Abnormalities due to Bepridil and Lidoflazine , 1990, Pacing and clinical electrophysiology : PACE.
[5] B. Fermini,et al. Amiodarone: Pharmacology, Clinical Actions, and Relationships Between Them , 1992 .
[6] A. Brown,et al. Bepridil block of cardiac calcium and sodium channels. , 1986, The Journal of pharmacology and experimental therapeutics.
[7] B. Fermini,et al. IK of rabbit ventricle is composed of two currents: evidence for IKs. , 1996, The American journal of physiology.
[8] D. Roden,et al. Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. , 1991, Circulation research.
[9] J. Pancrazio,et al. Verapamil-induced blockade of voltage-activated K+ current in small-cell lung cancer cells. , 1991, The Journal of pharmacology and experimental therapeutics.
[10] Nie Fe. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) , 1990 .
[11] B. Singh,et al. When is QT prolongation antiarrhythmic and when is it proarrhythmic? , 1989, The American journal of cardiology.
[12] M. Lazdunski,et al. Properties of KvLQT1 K+ channel mutations in Romano–Ward and Jervell and Lange‐Nielsen inherited cardiac arrhythmias , 1997, The EMBO journal.
[13] G. Klein,et al. Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome. , 1983, American heart journal.
[14] M. Weir,et al. The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .
[15] D. Escande,et al. KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane. , 1997, Molecular pharmacology.
[16] B. Attali. A new wave for heart rhythms , 1996, Nature.
[17] R. Brooks,et al. Pharmacology of Azimilide Dihydrochloride (NE-10064), A Class III Antiarrhythmic Agent , 1997 .
[18] G. Yellen,et al. Visual identification of individual transfected cells for electrophysiology using antibody-coated beads. , 1994, BioTechniques.
[19] S. Ertel,et al. Discovery and main pharmacological properties of mibefradil (Ro 40‐5967), the first selective T‐type calcium channel blocker , 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[20] G. Ducloux,et al. Nine cases of torsade de pointes with bepridil administration. , 1986, American heart journal.
[21] M. Gheorghiade,et al. Amiodarone therapy in chronic heart failure and myocardial infarction: a review of the mortality trials with special attention to STAT-CHF and the GESICA trials. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina. , 1997, Progress in cardiovascular diseases.
[22] Suppression of Torsades de Pointes with verapamil in patients with atrio-ventricular block. , 1991, European heart journal.
[23] P. Walter,et al. Anatomy of atrioventricular nodal reentry investigated by intracardiac echocardiography. , 1997, The American journal of cardiology.
[24] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.
[25] M. Sanguinetti,et al. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.
[26] R Lazzara,et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.
[27] T. DeCoursey. Mechanism of K+ channel block by verapamil and related compounds in rat alveolar epithelial cells , 1995, The Journal of general physiology.
[28] Bertram Pitt,et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.
[29] J. Hume. Comparative interactions of organic Ca++ channel antagonists with myocardial Ca++ and K+ channels. , 1985, The Journal of pharmacology and experimental therapeutics.
[30] S Nattel,et al. Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. , 1996, Circulation research.
[31] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[32] R. Sung,et al. Spectrum off electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease , 1996 .
[33] M. Sanguinetti,et al. Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.
[34] D. Snyders,et al. High affinity open channel block by dofetilide of HERG expressed in a human cell line. , 1996, Molecular pharmacology.
[35] A. Camm,et al. Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology. , 1993, American heart journal.
[36] G. Billman,et al. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation. , 1996, The Journal of pharmacology and experimental therapeutics.
[37] R. Sung,et al. Cellular and Clinical Electrophysiology of Verapamil‐Sensitive Ventricular Tachycardias , 1992 .
[38] Jacques Barhanin,et al. KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.